Gain-of-function mutations in leucine-rich repeat kinase 2 (LRRK2) cause familial as well as sporadic Parkinson’s disease characterized by age-dependent degeneration of dopaminergic neurons1,2. The molecular mechanism of LRRK2 action is not known. Here we show that LRRK2 interacts with the microRNA (miRNA) pathway to regulate protein synthesis. Drosophila e2f1 and dp messenger RNAs are translationally repressed by let-7 and miR-184*, respectively. Pathogenic LRRK2 antagonizes these miRNAs, leading to the overproduction of E2F1/DP, previously implicated in cell cycle and survival control3 and shown here to be critical for LRRK2 pathogenesis. Genetic deletion of let-7, antagomir-mediated blockage of let-7 and miR-184* action, transgenic expression of dp target protector, or replacement of endogenous dp with a dp transgene non-responsive to let-7 each had toxic effects similar to those of pathogenic LRRK2. Conversely, increasing the level of let-7 or miR-184* attenuated pathogenic LRRK2 effects. LRRK2 associated with Drosophila Argonaute-1 (dAgo1) or human Argonaute-2 (hAgo2) of the RNA-induced silencing complex (RISC). In aged fly brain, dAgo1 protein level was negatively regulated by LRRK2. Further, pathogenic LRRK2 promoted the association of phospho-4E-BP1 with hAgo2. Our results implicate deregulated synthesis of E2F1/DP caused by the miRNA pathway impairment as a key event in LRRK2 pathogenesis and suggest novel miRNA-based therapeutic strategies.
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Zimprich, A. et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601–607 (2004)
Paisan-Ruiz, C. et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease. Neuron 44, 595–600 (2004)
Girling, R. et al. A new component of the transcription factor DRTF1/E2F. Nature 362, 83–87 (1993)
Kim, J. et al. A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317, 1220–1224 (2007)
Schaefer, A. et al. Cerebellar neurodegeneration in the absence of microRNAs. J. Exp. Med. 204, 1553–1558 (2007)
Imai, Y. et al. Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila . EMBO J. 27, 2432–2443 (2008)
Gloeckner, C. J. et al. The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum. Mol. Genet. 15, 223–232 (2006)
West, A. B. et al. Parkinson’s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl Acad. Sci. USA 102, 16842–16847 (2005)
Pillai, R. S. et al. Inhibition of translational initiation by Let-7 microRNA in human cells. Science 309, 1573–1576 (2005)
Okamura, K., Ishizuka, A., Siomi, H. & Siomi, M. C. Distinct roles for Argonaute proteins in small RNA-directed RNA cleavage pathways. Genes Dev. 18, 1655–1666 (2004)
Johannes, G. et al. Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray. Proc. Natl Acad. Sci. USA 96, 13118–13123 (1999)
Hoglinger, G. U. et al. The pRb/E2F cell-cycle pathway mediates cell death in Parkinson’s disease. Proc. Natl Acad. Sci. USA 104, 3585–3590 (2007)
Neufeld, T. P., de la Cruz, A. F., Johnston, L. A. & Edgar, B. A. Coordination of growth and cell division in the Drosophila wing. Cell 93, 1183–1193 (1998)
Choi, W. Y., Giraldez, A. J. & Schier, A. F. Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. Science 318, 271–274 (2007)
Bilen, J. et al. MicroRNA pathways modulate polyglutamine-induced neurodegeneration. Mol. Cell 24, 157–163 (2006)
Xu, P., Vernooy, S. Y., Guo, M. & Hay, B. A. The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr. Biol. 13, 790–795 (2003)
Chan, S. P., Ramaswamy, G., Choi, E. Y. & Slack, F. J. Identification of specific let-7 microRNA binding complexes in Caenorhabditis elegans . RNA 14, 2104–2114 (2008)
Tain, L. S. et al. Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss. Nature Neurosci. 12, 1129–1135 (2009)
Tettweiler, G. et al. Starvation and oxidative stress resistance in Drosophila are mediated through the eIF4E-binding protein, d4E-BP. Genes Dev. 19, 1840–1843 (2005)
Meister, G. et al. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell 15, 185–197 (2004)
Du, W., Vidal, M., Xie, J. E. & Dyson, N. RBF, a novel RB-related gene that regulates E2F activity and interacts with cyclin E in Drosophila . Genes Dev. 10, 1206–1218 (1996)
Asano, M., Nevins, J. R. & Wharton, R. P. Ectopic E2F expression induces S phase and apoptosis in Drosophila imaginal discs. Genes Dev. 10, 1422–1432 (1996)
Rudel, S. et al. A multifunctional human Argonaute2-specific monoclonal antibody. RNA 14, 1244–1253 (2008)
Lee, Y. S. et al. Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell 117, 69–81 (2004)
Martin, S. G. & St Johnston, D. A role for Drosophila LKB1 in anterior–posterior axis formation and epithelial polarity. Nature 421, 379–384 (2003)
Miron, M. et al. The translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell growth in Drosophila . Nature Cell Biol. 3, 596–601 (2001)
Liu, Z. et al. A Drosophila model for LRRK2-linked parkinsonism. Proc. Natl Acad. Sci. USA 105, 2693–2698 (2008)
Brennecke, J. et al. bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila . Cell 113, 25–36 (2003)
Sokol, N. S., Xu, P., Jan, Y. N. & Ambros, V. Drosophila let-7 microRNA is required for remodeling of the neuromusculature during metamorphosis. Genes Dev. 22, 1591–1596 (2008)
Le Bacquer, O. et al. Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. J. Clin. Invest. 117, 387–396 (2007)
We thank R. W. Carthew, B. Dickson, B. Edgar, D. St Johnston, N. Sonenberg, W. Smith, Z. Zhang, H. Siomi, B. Hay, S. Cohen, the Vienna Drosophila RNAi Center and the Bloomington Drosophila Stock Center for fly stocks and cell line, and Bestgene Inc. for help with making gDPwt and gDPmut transgenics; N. J. Dyson, R. P. Wharton, C. Zeng, G. Meister and Y. Liu for antibodies; T. Tuschl, P. A. Sharp and Y. Tomari for plasmids; P. Sarnow and R. Cevallos for advice on polysome preparation; S. Guo and A. Fire for reading the manuscript; W. Lee and G. Silverio for technical support; and members of the Lu laboratory for discussions. This work was supported by the National Institutes of Health (R01AR054926, R01MH080378 and R21NS056878), the McKnight, Beckman and Sloan Foundations (B.L.), and the Program for Young Researchers from Special Coordination Funds for Promoting Science and Technology commissioned by MEXT in Japan and an Asahi Glass Foundation Research Grant (Y.I).
The authors declare no competing financial interests.
About this article
Cite this article
Gehrke, S., Imai, Y., Sokol, N. et al. Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 466, 637–641 (2010). https://doi.org/10.1038/nature09191
Journal of Cell Biology (2021)
TRIM-NHL as RNA Binding Ubiquitin E3 Ligase (RBUL): Implication in development and disease pathogenesis
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021)
Neurochemistry International (2020)
Noncoding RNAs and Midbrain DA Neurons: Novel Molecular Mechanisms and Therapeutic Targets in Health and Disease
The steroid‐induced microRNA let‐7 regulates developmental growth by targeting cdc7 in the Drosophila fat body
Insect Science (2020)